证券记录 · 已归档季度
BMY
Bristol-Myers Squibb Company · Healthcare · Drug Manufacturers - General
26被追踪持有人
0Δ持有人
840.35M持有股份
$37.89B报告持仓市值
+0新建仓位
−1清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 +0.8% · 净新建仓位 -3.8% · 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 2.35M | $122.19M | n/a | −2 |
| Q2 2026 | 172 | +1 | 1.32B | $76.14B | +6 | −6 |
| Q1 2026 | 175 | +1 | 1.27B | $76.90B | +4 | −4 |
| Q4 2025 | 173 | +1 | 1.36B | $73.29B | +2 | n/a |
| Q3 2025 | 26 | 0 | 840.35M | $37.89B | n/a | −1 |
| Q2 2025 | 24 | +1 | 649.62M | $30.06B | +2 | −1 |
| Q1 2025 | 20 | 0 | 256.22M | $15.62B | +1 | −1 |
| Q4 2024 | 20 | -1 | 253.42M | $14.33B | n/a | −1 |
| Q3 2024 | 20 | +1 | 169.93M | $8.78B | +1 | n/a |
| Q2 2024 | 19 | n/a | 159.17M | $6.60B | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 195.98M | +0.5% | $8.84B | 0.1% | ▲ Add | 2 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (被动) | 175.52M | +1.9% | $7.92B | 0.1% | ▲ Add | 2 | SEC ↗ ×21 |
| 3 | JPMorgan Chase ✦ | 172.36M | n/a | $7.77B | 0.2% | n/c | 1 | SEC ↗ ×44 |
| 4 | State Street Global Advisors ✦ (被动) | 96.60M | +2.0% | $4.36B | 0.2% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 46.55M | +0.8% | $2.10B | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 6 | Morgan Stanley ✦ | 27.87M | n/a | $1.26B | 0.1% | n/c | 1 | SEC ↗ ×23 |
| 7 | PRIMECAP Management ✦ | 22.09M | -3.7% | $996.45M | 0.8% | ▼ Trim | 6 | SEC ↗ |
| 8 | Goldman Sachs Group ✦ | 17.58M | n/a | $793.08M | 0.1% | n/c | 1 | SEC ↗ ×5 |
| 9 | Wellington Management ✦ | 17.16M | -33.6% | $773.74M | 0.1% | ▼ Trim | 6 | SEC ↗ ×6 |
| 10 | Arrowstreet Capital ✦ | 14.83M | +31.1% | $669.01M | 0.4% | ▲ Add | 6 | SEC ↗ |
| 11 | Fidelity (FMR) ✦ | 10.30M | -36.5% | $464.49M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 12 | AQR Capital Management ✦ | 9.46M | +56.0% | $426.35M | 0.3% | ▲ Add | 6 | SEC ↗ ×7 |
| 13 | T. Rowe Price ✦ | 7.72M | +6.1% | $348.13M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 14 | Dodge & Cox ✦ | 7.42M | -12.0% | $334.81M | 0.2% | ▼ Trim | 6 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 5.45M | +530.6% | $245.95M | 0.4% | ▲ Add | 6 | SEC ↗ |
| 16 | Renaissance Technologies ✦ | 3.67M | +5.4% | $165.41M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 2.47M | +169.7% | $109.71M | 0.1% | ▲ Add | 6 | SEC ↗ ×3 |
| 18 | Millennium Management ✦ | 2.27M | +759.6% | $102.48M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 19 | Marshall Wace ✦ | 1.53M | +32084.4% | $69.16M | 0.1% | ▲ Add | 2 | SEC ↗ ×2 |
| 20 | D. E. Shaw & Co. ✦ | 1.45M | +180.0% | $65.44M | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 21 | Gotham Asset Management ✦ | 698.22K | +14.8% | $31.49M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 22 | Adage Capital Partners ✦ | 580.06K | +196.0% | $26.16M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 23 | Bridgewater Associates ✦ | 444.03K | -83.6% | $20.03M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 24 | Fisher Asset Management ✦ | 216.14K | -4.8% | $9.75M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 25 | GAMCO Investors ✦ | 100.79K | -1.3% | $4.55M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 26 | Tweedy, Browne ✦ | 14.47K | +101.4% | $652,417 | 0.1% | ▲ Add | 2 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Norges Bank | $1.55B | 曾为 0.2% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1 持有人, 6.60K 股份, $400 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Sep 09
Massacesi Cristian
Officer · 6.25K 股 · $403,498
Aug 25
Holzer Phil M
Officer · 500 股 · $33,750
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 07
SC 13G: STATE STREET CORP
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据